ZIXI - Sector: Technology---Industry: Computer Services

[Terliso]

ZIXI is getting sexy.  Under $4 might be a possible target for this baby.

Thanks for the heads up Setravis, applause!

[setravis]

ZIXI is getting sexy.......I Hear You 
Volume...on your chart Terliso !
Volume seems to be the energy that makes the markets and individual stocks move.
If that is so, ZIXI should have a nice move higher in the future as volume has really increased !
Is at it's highest for the stock in ZIXI's history.

52wk Range: 0.51 - 2.05
Volume: 1,044,633
Avg Vol (3m): 668,335

Technicals
Record Price High

Last Price Quote is:
15.37%above 13-day MA
25.83%above 50-day MA
RS Rating: 98 

Fundamentals
Coverage Initiated: Buy

Key Data:
Market Cap (M): $39.96 
P/E Ratio: NA 
PEG Ratio: N/A 
Next Earnings: 05/08/2007
Last Analyst Rating: Buy

[Terliso]

InPlay: Zix Corp says "Preliminary rev ests are that we will be at least within our guidance range of $4.9 to $5.1 mln for the first quarter."

Zix Corporation CEO Provides Corporate Update
Monday April 9, 2:53 pm ET 
ZixCorp Significantly Exceeds First Quarter Cash Guidance as Company Collects Higher Than Expected Cash Receipts


DALLAS--(BUSINESS WIRE)--Zix Corporation (ZixCorp®), (Nasdaq:ZIXI - News), the leader in hosted services for email encryption and e-prescribing, today offered a corporate update by its chief executive officer, Rick Spurr.
ADVERTISEMENT


"ZixCorp's very strong first quarter built off the great momentum we had leaving 2006, which was the most successful year financially in the company's history," said Spurr. "I am very pleased with the tremendous progress we continue to make in cash consumption from operations. Our first quarter ending cash balance of $12.4 million was significantly ahead of our guidance range of $11.0 to $11.3 million, driven by higher than expected customer collections. The cash burn of less than $400,000 represents a substantial improvement over the fourth quarter 2006 rate of $2.1 million. However, the increase in cash receipts was due in part to collecting several payments originally forecasted for Q2, so at this point we expect the next quarter's cash consumption to increase over Q1's rate because of these timing shifts, and we are not yet adjusting our full-year cash guidance of burning less than $5.8 million. We do remain on track to achieve cash flow breakeven in 2008 on the way to profitability."

"We had a good start to the year in each of our core businesses - Email Encryption and e-Prescribing," continued Spurr. "Preliminary revenue estimates are that we will be at least within our guidance range of $4.9 to $5.1 million for the first quarter. In our Email Encryption business, we had a strong quarter in Q1 with estimated new first-year orders of $1.4 million, one of the highest results since we started tracking this metric, and estimated total orders of $5.2 million. This result was driven by a good quarter for both our enterprise and corporate telesales teams, and continued strength in the financial services sector and high customer renewals."

Regarding the company's e-prescribing business, Spurr said, "We had a good quarter in our PocketScript business as well. We had solid deployments of 507 for the quarter, the quarterly e-script count continues to increase with 1.76 million e-scripts in Q1, which was 50% above the rate in Q1 last year, and we announced our GoldRx(TM) status with SureScripts as an indication of our continued leadership in the industry. The level of activity in e-prescribing remains strong, so we are optimistic about our continued progress and maintaining our leadership position in this emerging market."

[setravis]

ZIX Report.......
The best thing about today's news,
ZixCorp Significantly Exceeds First Quarter Cash Guidance as Company Collects Higher Than Expected Cash Receipts. Backing and filling should occur but a good trend seems to have been established.

52wk Range: 0.51 - 2.18
Volume: 1,275,286
Avg Vol (3m): 709,511

Technicals
Record Price High

Last Price Quote is:
13.64%above 13-day MA
27.95%above 50-day MA
RS Rating: 98 

Fundamentals
Key Data:
Market Cap (M): $39.96 
P/E Ratio: NA 
PEG Ratio: N/A 
Next Earnings: 05/08/2007
Last Analyst Rating: Buy

[setravis]

ZIXI  to Announce First Quarter 2007 Results on May 8

Zix Corporation Earnings Conference Call (Q1 2007)
Scheduled to start Tue, May 8, 2007, 5:00 pm Eastern
Check back at the scheduled start time for
the audio link to appear in this spot. 

Link.......  http://biz.yahoo.com/cc/5/79625.html



Technicals
Record Price High
Percentage Gainer

Last Price Quote is:
14.21%above 13-day MA
30.01%above 50-day MA
RS Rating: 97 

Fundamentals
Key Data:
Market Cap (M): $124.90 
P/E Ratio: NA 
PEG Ratio: N/A 
Next Earnings: 05/08/2007
Last Analyst Rating: Buy

[BigSully1]

getting a nice bounce today.

[setravis]

Zix Corp says to meet or exceed Q2 revenue view
Tue Jul 10, 2007 9:37AM EDT
said it will meet or exceed its second-quarter revenue outlook range of $5 million to $5.3 million.
Two analysts on average expect the company to post revenue of $5.3 million for the second quarter, according to Reuters Estimates. (Reporting by Nitya Rao in Bangalore)


Zix Corporation Earnings Conference Call (Q2 2007)
Scheduled to start Tue, Aug 7, 2007, 5:00 pm Eastern



Press Release Source: Zix Corporation


Zix Corporation CEO Provides Corporate Update
Tuesday July 10, 9:15 am ET 
ZixCorp Once Again Exceeds Quarterly Cash Guidance and Remains on Track to Achieve Positive Cash Flow


DALLAS--(BUSINESS WIRE)--Zix Corporation (ZixCorp®), (Nasdaq:ZIXI - News), the leader in email encryption and e-prescribing services, today offered a corporate update by its chief executive officer, Rick Spurr.


"ZixCorp continues to perform ahead of plan in 2007, specifically with respect to our net cash consumption," said Spurr. "I am very pleased that we were able to maintain the strong results this quarter that we delivered in Q1. Our second quarter ending cash balance of $12.1 million was well ahead of our guidance range of $11.3 to $11.5 million. The cash burn for the first half of this year of $700,000, compared with an $11.5 million burn for the first half of last year, is due to significant increases in cash receipts from both the Email Encryption and e-Prescribing businesses coupled with the tremendous operational improvements we have made over the past year. Even with fourth quarter's seasonal decrease in Email Encryption cash collections and annual expenditures typically made in Q4, we remain on track to burn less than $4.8 million for all of this year and to achieve positive cash flow as we enter 2008 on the way to profitability."

"We had a good quarter in each of our core businesses - Email Encryption and e-Prescribing," continued Spurr. "Preliminary company-wide revenue estimates are that we will meet or exceed our guidance range of $5.0 to $5.3 million. In our Email Encryption business, we had a strong quarter for new order bookings with estimated new first-year orders of $1.4 million and estimated total orders of $6.9 million, which is by far a record for this business and more than 25 percent higher than any previous quarter. We saw continued demand for our service model in both healthcare and financial services, and high customer satisfaction as evidenced by strong renewals."

Regarding the Company's e-prescribing business, Spurr said, "We had a solid quarter in our PocketScript business as well. We had increased deployments of 557 for the quarter, the quarterly e-script count continued to grow with 1.84 million e-scripts in Q2, and our customers continue to see significant value from our service and remain highly satisfied. To that point, we had two customers, Independence Blue Cross and Aetna, sign up in Q2 to pay for renewals of their active prescribers, which, along with previous contracts and other expressions of intent to do the same, means that six out of our seven programs have decided to renew the subscription license for their active prescribers. We continue to see a high level of interest in the market and expect to announce new pilots in the second half of the year."

ZixCorp to Announce Second Quarter 2007 Results on August 7

The Company's second quarter 2007 operating results will be released after close of the U.S. financial markets on August 7, 2007. The company will hold a conference call to discuss this information on August 7 at 5:00 p.m. ET.

A live Webcast of the conference call will be available on the investor relations portion of ZixCorp's Web site at http://investor.zixcorp.com. Alternatively, participants can listen to the conference call by dialing 617-597-5380 or toll-free 866-510-0712 and entering access code 60467146. An audio replay of the conference will be available until August 14, by dialing 617-801-6888 or toll-free 888-286-8010, and entering the access code 64920829, and after that date via Webcast on the Company's Web site.

About Zix Corporation

ZixCorp is the leading provider of easy-to-use-and-deploy email encryption and e-prescribing services that Connect entities with their customers and partners to Protect and Deliver sensitive information in the healthcare, finance, insurance and government industries. ZixCorp's hosted Email Encryption Service provides an easy and cost-effective way to ensure customer privacy and regulatory compliance for corporate email. Its PocketScript® e-prescribing service reduces costs and improves patient care by automating the prescription process between payors, doctors, and pharmacies. For more information, visit www.zixcorp.com.

Safe Harbor Statement for ZixCorp

The following is a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are not guarantees of future performance and involve risks and uncertainties. Actual results may differ materially from those projected in the forward-looking statements. These risks and uncertainties include, but are not limited to, the following: the company's continued operating losses and utilization of cash resources; the company's ability to achieve broad market acceptance for the company's products and services, including the company's ability to enter into new sponsorship agreements for the e-prescribing services offered by its PocketScript, Inc. subsidiary and the company's ability to achieve market acceptance of its Email Encryption business in markets other than the healthcare market; the company's ability to maintain existing and generate other revenue opportunities, including fees for scripts written, from its PocketScript e-Prescription business; the company's ability to establish and maintain strategic relationships to gain customers and grow revenues, particularly in its Email Encryption business; the expected increase in competition in the company's Email Encryption and e-Prescription businesses; and the company's ability to successfully and timely introduce new Email Encryption and e-Prescription products and services or related products and services and implement technological changes. Further details on such risks and uncertainties may be found in the company's public filings with the SEC.

Contact:
ZixCorp
Public Relations:
Farrah Corley, 214-370-2175
[email protected]
or
Investor Relations:
Peter Wilensky, 214-515-7357
[email protected]

--------------------------------------------------------------------------------
Source: Zix Corporation

[setravis]

BreakOut on strong guidance.......  (see CEO's comments).
It's had a nice pull back, tested the $1.69-1.70 area and held,
it's at the bottom of its uptrend channel. 
Looks like a good time to buy....... looks like $3.00+ is doable
Seems like the company is in a turnaround.
 
MACD going positive. Stochastic rising out of oversold.
Support @ $2.07...1.95...1.88
Resistance @ $2.29...2.45

Recent CandleStick Analysis
Bullish
Jul-09-2007 Inverted Hammer 
Jul-06-2007 Bearish Engulfing 
Jul-05-2007 Bullish Engulfing 

52wk Range: 0.51 - 2.49
Volume: 835,606
Avg Vol (3m): 299,383

Technicals
13-day MA Cross Above 50-day MA
Percentage Gainer

Last Price Quote is:
11.19%above 13-day MA
11.49%above 50-day MA
RS Rating: 65 

Fundamentals
Key Data:
Market Cap (M): $107.40 
P/E Ratio: NA 
PEG Ratio: -0.2875 
Next Earnings: 08/07/2007
Last Analyst Rating: Buy

[setravis]

ZIXI may be a "Diamond Chip" in the rough.
This is a nice little company with some solid contracts.
ZIXI should be a nice long term hold,
It may take quite a while for the stock price to move higher, particularly over $5 where institutions can purchase.

setravis's Coverage Initiated...
The Industry's Leading Hosted Email Encryption Service,
ZIXI scored the FDIC as a customer.......
Nice insider buying  http://finance.yahoo.com/q/it?s=ZIXI
Good Volume...
Volume has picked up lately. Hope that it will continue.
This appears to be in the early stages of accumulation after a tremendous decline from the upper teens.
Has had a Breakout from Inverted Head and Shoulder Bottom (reversal)  and a move past $1.5-$1.6 resistance area will draw in more buyers.

Volume has picked up lately. Hope that it will continue.
This appears to be in the early stages of accumulation after a tremendous decline from the upper teens.
Has had a Breakout from Inverted Head and Shoulder Bottom (reversal)  and a move past $1.5-$1.6 resistance area will draw in more buyers.

ZIXI is getting sexy.  Under $4 might be a possible target for this baby.

Thanks for the heads up Setravis, applause!

The signs were there.......If you fail to follow, You will fail to make those profits!
ZIXI is zig-zagging higher with the previous zig-zag low at $2.79 , the previous zig-zag high was $2.92
There's a few glaring indicators which are very useful here.
Look at the stochastic, it never hits oversold (my favorite indicator)
The MACD uptrend dropped back to the 13-day MA, and then volume increased at the 13-day MA, and the following day was followed by more volume.
"Overextended", I hesitate to agree with anyone on this because it finished at or near the high of the days trading range, one push might be in the making !

Note: It's always nice to split your initial purchase if you can. Even if you only leave 100 shares left in the market, then you'll get the feel for being "in" and you'll be able to gauge your emotions in the trade...

My favorite clincher with ZIXI is the contract they scored with the FDIC. Eprescirptions are a must going forward, so the technicals are supported by real life economics and strong demand for their products and services.

The target price is 293% higher than Friday's closing price. The move to this price will not be straight up and may take a year to get there, that is my fellow traders here @ 3SOF long tern investing. It take some patients !

52wk Range: 0.91 - 4.16
Volume: 3,471,118
Avg Vol (3m): 534,089

Technicals
Record Price High
Percentage Gainer

Last Price Quote is:
32.23%above 13-day MA
68.61%above 50-day MA
RS Rating: 99 

Fundamentals
Earnings Expected on Nov 8

Key Data:
Market Cap (M): $213.00 
P/E Ratio: NA 
PEG Ratio: -0.5525 
Next Earnings: 11/08/2007
Last Analyst Rating: Buy






 

[setravis]

These low-priced stocks will outperform the market.......Make some change     
Crystallex International (AMEX: KRY)
Zix (Nasdaq: ZIXI)
Beacon Power (Nasdaq: BCON)


Zix Corporation Earnings Conference Call (Q3 2007)
Scheduled to start Thu, Nov 8, 2007, 5:00 pm Eastern

Check back at the scheduled start time for
the audio link to appear in this spot.
Link....... http://biz.yahoo.com/cc/9/85439.html

[Livana]

Picked up ZIXI at 2.68.  I wasn't paying attention today when I saw the buy order go through.  I was surprised by the dip.  Hope it recovers quickly.  We're already back at $2.81 (2:20pm).

The reason behind today's downturn:

Zix Corp downgraded by Collins Stewart - I love it when these "analysts" downgrade good stocks.  Creates a perfect buy opportunity.

Yesterday's results were, I guess, expected:

Zix Q3 results

Oh, and thanks and applaud to setravis for pointing this one out 

[Livana]

Release:

Wed, Nov 14
ZIX CORP Files SEC form 10-Q, Quarterly Report

Tue, Nov 13
Zix Corporation Positioned in Leader's Quadrant for 2007 Email Encryption Magic Quadrant

[setravis]

Is the stock building out the right side of a reverse Head and Shoulders pattern or will it blow through the $4.00 area on this move up? That is the question!
The answer should be known next week...
Very good week from a technical point of view. Good OBV. Some rumors about Medicare mandating e-Prescriptions in the near future may be adding to the recent move and future stock progress.
Great technicals, bounced off the 50-day MA, back above the 13-day...
Some good looking volume days and again on Friday.




52wk Range: 0.91 - 4.16
Volume: 1,446,890
Avg Vol (3m): 754,039

Technicals
Percentage Gainer

Last Price Quote is:
11.66%above 13-day MA
29.77%above 50-day MA
RS Rating: 98 

Fundamentals
Key Data:
Market Cap (M): $217.22 
P/E Ratio: NA 
PEG Ratio: N/A 
Next Earnings: 02/19/2008
Last Analyst Rating: Market Perform

[setravis]

Press Release Source: Zix Corporation


Statement by ZixCorp Supporting John Kerry and Newt Gingrich's e-Prescribing Call to Action
Monday November 19, 1:00 pm ET
Largest Standalone e-Prescribing Company in the U.S. Attests to Benefits


DALLAS, Nov. 19, 2007 (PRIME NEWSWIRE) -- Zix Corporation (ZixCorp(r)), (NasdaqGM:ZIXI - News), the leader in hosted services for email encryption and e-prescribing, issued a statement supporting Friday's Wall Street Journal commentary by John Kerry and Newt Gingrich promoting the importance of modernizing healthcare with life-saving e-Prescribing technology(1).


``We have seen results in multiple payor-sponsored programs showing how e-prescribing positively impacts patient safety and reduces the cost of healthcare in the United States.'' said Rick Spurr, chief executive officer for ZixCorp. ``e-Prescribing is a win-win for all stakeholders in the healthcare system, including providers, payors, pharmacies, and most certainly patients. We are thrilled to see that e-Prescribing can be a unifying issue that can draw bipartisan support and we applaud Mr. Kerry and Mr. Gingrich for their call for leadership on this issue.''

ZixCorp fully supports the proposals outlined in the Kerry/Gingrich commentary, including a government requirement for e-prescribing combined with appropriate physician incentives. ZixCorp believes that these steps together with support from private health plans to ease the burden of implementation, training and support, will accelerate the adoption of e-Prescribing resulting in a reduction in both medication errors and the cost for prescriptions.

The eRx Collaborative, ZixCorp's longest-running payor-sponsored e-Prescribing program, which was formed by Blue Cross Blue Shield of Massachusetts, Tufts Health Plan and Neighborhood Health Plan in 2003, publicly stated that as of June 30, 2007, approximately 50,000 electronic prescriptions were changed during the first half of 2007 by the physician due to drug safety alerts, 2.1 percent of the electronic prescriptions written. Blue Cross and Blue Shield of Massachusetts has also documented a 3.0 to 3.5 percent savings in drug spending for the health plan and a $20-$25 savings per prescription for the patient in cases where physicians use e-prescribing compared with those who were not using the technology. More recently, Aetna announced that it had experienced a five to seven percent increase in use of on-formulary and generic drugs, respectively, in its New Jersey e-Prescribing pilot with ZixCorp, which also facilitates drug-drug and drug-allergy safety checks to increase patient safety.

As a pioneer in the e-prescribing industry, ZixCorp has been the leader in bringing stand-alone e-prescribing technology to physicians across the country. ZixCorp has had particular success in introducing this life-saving technology to small practices with one or two doctors, where about half of the primary care providers in the U.S. practice today. This segment of the physician market has been largely neglected in the push for the adoption of healthcare IT, and ZixCorp strongly believes that e-prescribing is a cost-effective and easy-to-implement technology that reaps significant benefits for these physicians and their patients today, as well as provide the solid platform for the adoption of additional technology tomorrow.

As further evidence that e-prescribing continues to gain momentum, on November 16, Centers for Medicare and Medicaid Services released proposed rules to adopt standards to advance the use of e-Prescribing for formulary, benefit and medication history transactions under the Medicare prescription drug benefit. In addition to Messrs. Kerry and Gingrich, several other groups have recently called for the widespread adoption of e-prescribing, including the American Health Information Community (a U.S. Department of Health and Human Services advisory body), the Blue Cross and Blue Shield Association, the Pharmaceutical Care Management Association, 13 of the leading pharmacy software companies, and a coalition of consumer and business organizations.

ZixCorp's PocketScript(r) e-prescribing service enables physicians to order prescriptions through a secure wireless mobile PDA or secure Web site and deliver them electronically to the patient's preferred pharmacy. Mobility enables PocketScript to provide clinical decision support at the point-of-care with real-time access to a drug reference guide as well as patient-level eligibility, formulary, and co-pay information to aid the prescriber in selecting the most cost-effective prescription based on the patient's benefits. The application also provides comprehensive drug-to-drug and drug-to-allergy interaction alerts based on patient-specific dispensed drug history. Through partnerships with RxHub and RelayHealth, and as a SureScripts GoldRx Certified Solution, PocketScript delivers end-to-end connectivity within the healthcare system to reduce unnecessary costs, improve patient safety and convenience, and enhance practice efficiency.

About Zix Corporation

ZixCorp is the leading provider of easy-to-use-and-deploy email encryption and e-prescribing services that connect entities with their customers and partners to protect and deliver sensitive information in the healthcare, finance, insurance and government industries. ZixCorp's hosted Email Encryption Service provides an easy and cost-effective way to ensure customer privacy and regulatory compliance for corporate email. Its PocketScript(r) e-prescribing service saves lives and saves money by automating the prescription process between payors, doctors and pharmacies. For more information, visit http://www.zixcorp.com.

The Zix Corporation logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4086



(1) Kerry, J., Gingrich, N. (2007, November 16). E-Prescriptions
     The Wall Street Journal, p. A20



Contact:
          ZixCorp
          Public Relations:
          Farrah Corley
            (214) 370-2175
            [email protected]
          Investor Relations:
          Peter Wilensky
            (214) 515-7357
            [email protected]


--------------------------------------------------------------------------------
Source: Zix Corporation

[setravis]

ZIXI is definitely gaining a following !
Moving up...Good volume and rate of change. High profits possible from the looks of the graph.
Good news, ZIXI as of today's close has higher lows and higher highs.
The theory is that if a stock makes a new high it is good to see a new high accumulative volume. If this does not occur the stock may move lower. Volume is like the gas in a car, it makes it go. Of course both a car and a stock can coast farther once it is running out of gas.



52wk Range: 0.91 - 4.16
Volume: 1,262,026
Avg Vol (3m): 775,022

Technicals
Percentage Gainer

Last Price Quote is:
14.51%above 13-day MA
33.65%above 50-day MA
RS Rating: 99 

Fundamentals
Key Data:
Market Cap (M): $217.22 
P/E Ratio: NA 
PEG Ratio: N/A 
Next Earnings: 02/19/2008
Last Analyst Rating: Market Perform